investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Papillomavirus E6 Structural Consortium
Scott B Vande Pol
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Scott B Vande Pol
University of Virginia
Charlottesville, United States
Gilles Trave
Louis Pasteur University
Strasbourg, France
Related projects
Casey Farquhar
AIDS International Training and Research Program
Cervix uteri
Edward N Okeke
The Demand for Cancer Screening: Peer Effects or Learning
Cervix uteri
Barry O'Keefe
Isolation of Antiviral Proteins from Natural Product Extracts
Cervix uteri
Tzyy-Choou Wu
Upregulation of Nanog as an Innovative Mechanism for Cancer Drug Resistance
Cervix uteri
Karl Munger
Biological Activity of HPV E7 in Human Epithelial Cells
Cervix uteri
Pathology
Harold M Swartz
Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy
Cervix uteri
Radiation Oncology
Investigator from Johns Hopkins University
Tissue-based Prediction of Response to Immunotherapy in HPV Disease
Cervix uteri
Denise A. Galloway
Interactions of HPV Oncogenes With the p53 Pathway
Cervix uteri
Needs Assessment to Assess Barriers to Developing a Comprehensive Cancer Center in LMICs
Cervix uteri